cetirizine has been researched along with Nasal Polyps in 3 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cetirizine was found to reduce nasal sneezing and rhinorrhoea effectively." | 2.69 | The effect of cetirizine on symptoms and signs of nasal polyposis. ( Aanesen, JP; Burtin, B; Donnelly, F; Duby, C; Haye, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, CS | 1 |
| Cho, JH | 1 |
| Kang, JM | 1 |
| Kim, BK | 1 |
| Han, MA | 1 |
| Papon, JF | 1 |
| Coste, A | 1 |
| Gendron, MC | 1 |
| Cordonnier, C | 1 |
| Wingerstmann, L | 1 |
| Peynègre, R | 1 |
| Escudier, E | 1 |
| Haye, R | 1 |
| Aanesen, JP | 1 |
| Burtin, B | 1 |
| Donnelly, F | 1 |
| Duby, C | 1 |
1 trial available for cetirizine and Nasal Polyps
| Article | Year |
|---|---|
The effect of cetirizine on symptoms and signs of nasal polyposis.
Topics: Adult; Aged; Anti-Allergic Agents; Cetirizine; Double-Blind Method; Drug Administration Schedule; Fe | 1998 |
2 other studies available for cetirizine and Nasal Polyps
| Article | Year |
|---|---|
Levocetrizine has anti-inflammatory effects against Toll-like receptor (TLR)3 through the inhibition of Toll-IL-1 receptor (TIR)-domain-containing adapter inducing IFN-beta (TRIF) and receptor-interacting protein (RIP).
Topics: Adaptor Proteins, Vesicular Transport; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; | 2011 |
HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps.
Topics: Analysis of Variance; Cells, Cultured; Cetirizine; Dexamethasone; Epithelial Cells; Flow Cytometry; | 2002 |